Drug comparisons
Saxagliptin vs Rosiglitazone
Compare Saxagliptin (Onglyza) vs Rosiglitazone for type 2 diabetes. Review mechanisms, efficacy, side effects, CV risks, weight impact and patient suitability.
No comparison dimensions are available for this page.
Clinical context
This comparison is triggered for type 2 diabetes patients needing an alternative oral agent due to inadequate A1C control, weight concerns, or cardiovascular comorbidities.
Bottom line
Saxagliptin is generally preferred over rosiglitazone due to lower heart failure and fluid retention risks, though neither is ideal for all patients.
All medication comparisons